Windlesham, Surrey, United Kingdom
Head of In Vivo Pharmacology at Eli Lilly, Erl Wood
Pharmaceuticals
Education
University of Cambridge 1987 — 1990
PhD, Experimental Psychology
Coventry University 1980 — 1984
BSc Hons, Applied Biology
Experience
Eli Lilly and Company January 2014 - Present
University of St Andrews May 2012 - Present
TPP Global Development Ltd January 2011 - December 2013
MSD January 2010 - January 2011
Schering-Plough Research Institute January 2009 - January 2010
Schering-Plough 2007 - 2009
Organon Pharmaceuticals December 2001 - 2007
University of Edinburgh January 1993 - December 2001
National Institute on Drug Abuse January 1991 - December 1992
University of Cambridge 1987 - 1990
Skills
Neurology, Biotechnology, Clinical Research, In Vitro, Pharmacokinetics, Assay Development, Lifesciences, Project Management, Neuroscience, Laboratory, Cognition, Translational Research, In Vivo, Physiology, Psychopharmacology, Life Sciences, Neurodegeneration, Pharmacology, Biochemistry, Pharmaceutical Industry, Drug Discovery, Clinical Development, Immunology, Psychiatry, Preclincal models, CRO, Management, Neuropharmacology, Drug Development, Animal Models, Toxicology, Biomarker Discovery, Biomarkers, Translational Medicine, Project mangement, Research, Animal Behavior